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Structural Neurology: Minireview
Are Seeds at the Root
of Neuronal Degeneration?
chronic brain diseases in which ordered protein poly-
merization is endogenously seeded. A detailed under-
standing of this process may shed new light on the
etiology of these diseases, allow risk factors to be identi-
fied, and pave the way for more effective and specific
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Ordered Aggregation Requires
the Formation of a SeedAge-related neurodegenerative diseases form a clini-
In contrast to the formation of amorphous precipitate,cally and neuropathologically diverse group that in-
ordered aggregation proceeds via a nucleus (or seed),cludes common sporadic diseases such as Alzheimer's
the formation of which is slow due to the high entropicdisease (AD) and Parkinson's disease (PD), both of
cost of organizing a series of specific intermolecularwhich also occur in relatively rare early-onset familial
interactions. Seeded polymerization will not occur be-forms; purely familial diseases such as Huntington's dis-
low a certain protein concentration known as the criticalease (HD); and ªinfectiousº prion diseases, which are
concentration (dark green zone in phase diagrams intransmissible. That each of these diseases is character-
Figure 1). Above this concentration, aggregation will notized by abnormal protein deposition in the brain has
necessarily occur immediately (the rate of polymeriza-been documented, although a causal role for deposition
tion can be extremely sensitive to protein concentra-in neurodegeneration has not been proven. However,
tion), giving rise to a metastable supersaturated statethe significance of the fact that abnormal protein deposi-
(light green zone). Addition of preformed ordered aggre-tion is a shared feature of all of these diseases has
gate, or ªseed,º to a supersaturated solution will resultperhaps been underappreciated. It is the purpose of this
in immediate aggregation (elimination of the light greenMinireview to draw attention to existing evidence that
zone; see lower-right phase diagram). Crystallization,suggests that the mechanism of protein aggregation
microtubule formation, and sickle-cell hemoglobin fibril-and deposition may also be shared and to identify corol-
lization are examples of seeded polymerizations (Eatonlaries of this hypothesis that suggest experimental tests
and Hofrichter, 1995; Harper and Lansbury, 1997).of its veracity.
The characteristic amyloid plaques of AD and the
In Vitro Formation of Ab Amyloid and PrPScscrapie-associated fibrils of the prion diseases contain
Involve Seeded Protein Polymerizationdifferent proteins: the b-amyloid protein (Ab, z4 kDa)
Brain-derived Ab amyloid and PrPSc exhibit similar or-and the prion protein (PrP, z30 kDa), respectively. (Prus-
dered fibrillar morphology, suggesting that both resultiner, 1997; Selkoe, 1997) Ab and PrP are normally solu-
from seeded polymerization. Although the mechanisticble, but in the disease state are converted to forms that
details of the in vivo processes are extremely difficult toare fibrous and relatively resistant to chemical denatur-
elucidate, invitro model studies support this suggestion.ation and proteolytic digestion (Ab amyloid fibril and
The in vitro formation of amyloid fibrils, including thosePrPSc). Conversion involves a change in the three-dimen-
comprising Ab, occurs via seeded polymerization. Absional rather than the covalent structure of these pro-
fibrils comprising Ab40 or the minor variant Ab42, whichteins. The conversion of Ab to amyloid fibrils seems to
forms fibrils much more rapidly than Ab40 in vitro, seedbe indirectly promoted in early-onset familial AD (FAD)
polymerization of Ab40 (Harper and Lansbury, 1997).by mutations in three genes (amyloid precursor protein
Significantly, of 11 FAD mutations that have been ana-[APP] and presenilins 1 and 2) that increase its produc-
lyzed in various ways, all increase Ab42 production whiletion (Selkoe, 1997). Alternatively, the conversion of PrP
only one also increases Ab40 production (Selkoe, 1997).to PrPSc may be directly promoted in the familial prion
Together, these data strongly suggest that Ab42 maydiseases by mutations in the gene encoding PrP that
produce the pathogenic seed. The in vitro formation offacilitate unfolding and/or aggregation (Prusiner, 1997).
PrPSc from the soluble cellular prion protein, using brain-Recently, protein aggregation has also been implicated
derived PrPSc as seed, also has properties of a seededin PD and the group of neurodegenerative diseases as-
polymerization, although this model system has not yetsociated with polyglutamine repeats, including HD and
been proven to precisely mimic the in vivo processspinocerebellar ataxia type III (SCA3).
(Caughey et al., 1995).The properties of these stable pathogenic protein ag-
gregates (i.e., Ab amyloid and PrPSc) suggest that their
formation involves seeded polymerization of the constit- Huntington's Disease and Familial Parkinson's
Disease Are Both Caused by Mutationsuent proteins (i.e., Ab and PrP; Harper and Lansbury,
1997). This hypothesis may also provide a simple expla- in Genes that Encode Proteins
Found in Disease-Associatednation for the transmissability of the prion diseases: the
ªinfectiousº particle may be an exogenous seed for PrP Fibrillar Aggregates
HD and SCA3, both of which are caused by expansionpolymerization. PD, SCA3, and HD may also involve
ordered aggregation, and they may, together with AD of preexisting polyglutamine tracts in otherwise unre-
lated proteins (huntingtin and ataxin-3, respectively), areand the prion diseases, constitute a large group of
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Figure 1. Protein Concentration and the Du-
ration of Supersaturation Both Affect the Pro-
cess of Ordered Aggregation
The process of ordered protein aggregation
(e.g., amyloid formation and PrPSc formation)
depends on protein concentration and the
time during which supersaturation is main-
tained. This leads to a time-dependent phase
diagram containing three regions. The black
circle represents the in vivo conditions. If
these conditions fall in the red zone, aggrega-
tion will occur and disease will result. If they
fall in either of the two green zones, no aggre-
gation will occur. This zone is likely to be
experienced in ªnormalº metabolism (black
circle). Several scenarios could trigger aggre-
gation (a move of the black circle into the red
zone).
characterized by abnormal nuclear inclusions in the af- this is the basis of cloud seeding. Thus, onemight expect
that seeds arising from mutant proteins may promotefected brain regions (DiFiglia et al., 1997; Paulson et al.,
1997). These nuclear inclusions contain the polygluta- polymerization of wild-type (wt) protein. Indeed, depos-
its from brain tissue of individuals heterozygous formine-containing proteinsand can be inducedby expres-
sion of an expanded polyglutamine domain in transgenic early-onset mutations often contain the wt protein along
with the mutant protein. In some, but not all, forms ofmice (Davies et al., 1997). Significantly, a recombinant
polyglutamine-containing protein similar to the protein familal prion disease, wt PrP and mutant PrP are both
found in the disease-associated PrPSc (Chen et al., 1997;expressed in transgenic mice forms amyloid fibrils in
vitro (Scherzinger et al., 1997). Silvestrini et al., 1997). It has not yet been determined
whether familial PD Lewy bodies contain wt as well asThe subcortical region of sporadic PD brain is charac-
terized by fibrous cytoplasmic inclusions called Lewy mutant a-synuclein or whether HD-associated nuclear
inclusions contain wt huntingtin as well as the expandedbodies, of which the protein a-synuclein (also called
NACP) is a constituent (Spillantini et al., 1997). Recently, variant (nuclear inclusions in transgenic mice do not
appear tocontain endogenous huntingtin). In cell culturea point mutation in the a-synuclein gene has been linked
to a rare form of early-onset familial PD (Polymeropoulos models of SCA3, wt ataxin-3 is recruited into nuclear
inclusions along with the coexpressed mutant proteinet al., 1997). Whether the PD mutation increases the
tendency of a-synuclein to polymerize, analogous to the (Paulson et al., 1997).
In HD, familial PD, and familial prion disease, muta-apparent action of PrP mutations associated with prion
diseases, has not been determined. tions may directly stabilize the seed, accelerating its
formation. In contrast, FAD mutations, which do notIt is interesting that cortical Lewy bodies often coexist
with amyloid plaques in AD brain (ªLewy body variantº involve the Ab sequence, may indirectly promote seed-
ing by selectively increasing the production of Ab42.of AD) and FAD brain and are also characteristic of
diffuse Lewy body disease (DLBD), an age-related de- The FAD abnormality (analogous to the mutant protein)
is increased Ab42, whereas Ab40 is normal (analogousmentia lacking amyloid plaques but often confused with
AD in the clinic (Kosaka and Iseki, 1996). The involve- to wt). However, once again the normal protein is in-
volved in the abnormal polymerization: amyloid derivedment of the Lewy body in both AD and PD, albeit in
separate regions of the brain, taken together with evi- from the brains of FAD individuals contains Ab40, as do
plaques from Down's syndrome AD patients (Selkoe,dence that certain factors may increase susceptibility
for both AD and PD, suggests that a common mecha- 1997). These may be additional examples of disease-
associated mutations accelerating seeded polymeriza-nism may be involved in pathogenesis of all of these
diseases. tion of the normal protein.
The a-Synuclein Protein and Gene Have
Been Implicated in Both AD and PDBiochemical Evidence Suggests that Seeded
Polymerization May Be a Shared a-Synuclein is found in AD amyloid plaques and in PD
Lewy bodies. A mutation in the a-synuclein gene hasPathogenic Mechanism
Disease-Associated Mutations May Promote been linked to familial PD (Polymeropoulos et al., 1997),
and a polymorphism in its promoter seems to modifyNucleation and Cause Seeding of Wild-Type
Protein Polymerization the AD risk of individuals bearing the apoE4 risk factor
(Xia et al., 1996). A peptide containing a partial a-synu-Seeding can be accomplished by a heterologous mate-
rial that is complementary to the polymer of interest. clein sequence forms amyloid fibrils that seed Ab40
polymerization in vitro (Harper and Lansbury, 1997).For example, ice formation is seeded by silver iodide;
Minireview
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The Seeded Polymerization Scenario Provides factor in sporadic AD, PD, and HD. Alternatively, the
endogenously generated seed may be heterologousÐan Explanation for Known Genetic Effects
and Suggests Candidate Susceptibility that is, derived from a molecule other than the aggregat-
ing protein in a form that just happens to effectivelyFactors for Future Study
Under normal conditions, amyloidogenic proteins may seed its polymerization. Many candidates for this heter-
ologous seed (e.g., glycolipid, proteoglycan, and serumbe exposed to supersaturating conditions but for peri-
ods of time insufficient toallow nucleation (black circle in amyloid P component) have been suggested.
light green zone in upper-left phase diagram). Abnormal
conditions that allow nucleation to occur (red zone in Is the Seed a Viable Therapeutic Target?
Because the biochemical mechanisms of neuronal deathphase diagrams) in vivo could promote disease. Several
possibile scenarios are discussed below and illustrated in these diseases remain a mystery, the available thera-
pies target the consequences of neuronal loss (e.g.,in Figure 1.
Germline Mutations May Promote Nucleation L-DOPA for PD and acetylcholinesterase inhibitors for
AD), rather than its underlying cause. If seeding of poly-By lowering the barrier to nucleus formation, mutations
could cause the metastable region to shrink to the point merization is the underlying cause, then the seed, or
better yet its precursors, could be a target for therapeu-that ªnormalº conditions ([protein] and time) are suffi-
cient to allow nucleation (upper-right phase diagram). tic intervention. By inhibiting nucleation, one could in-
crease the size of the light green metastable region,Point mutations in PrP and a-synuclein, the insertion of
additional repeat sequences in the N-terminal domain thus providing protection against all of the age-related
changes discussed above. This strategy has been effec-of PrP, and the expansion of the polyglutamine domains
in the proteins associated with triplet expansion dis- tive in the inhibition of sickle-cell hemoglobin fibrilliza-
tion and the treatment of sickle-cell anemia (Eaton andeases may all promote nucleation.
Compromised Chaperone or Protease Hofrichter, 1995). Inhibitory activity against Ab amyloid
fibril nucleation has been demonstrated by proteinsFunction Could Allow Nucleation
A decrease in the efficiency of the chaperone or proteo- such as apoE and by small drug-like molecules (Harper
and Lansbury, 1997). The challenge will be to devise asome systems, both of which deal with partially folded
or misfolded proteins, could allow nucleation to occur nucleation inhibitor that is specific for the seed-produc-
ing protein±protein interaction, is efficiently transportedmore easily, causing a shrinkage of the light green meta-
stable zone (upper-right phase diagram). Such a de- to the brain, and is free of side-effects and toxicity,
since chronic administration is likely to be necessary.crease could be linked to aging.
Factors that Prolong Supersaturation In addition, it will be desirable to treat at-risk individuals
before the appearance of symptoms, at which time pro-Would Allow Nucleation
tein deposition is advanced and neurodegeneration isProlonging the existence of the supersaturated state,
effectively irreversible.by decreasing either proteolysis or the efficiency of neu-
ronal protein trafficking, could give nucleation the op-
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